Delving into the Latest Updates on Bellwyck Pharma Services Inc with Synapse

Overview

Tags

Nervous System Diseases

Immune System Diseases

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1
Immune System Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

VGSCs(Voltage-gated sodium channels)	1

Primary Objective: To evaluate the efficacy of Cenobamate as an add-on treatment compared to placebo in subjects with POS. Secondary Objectives: To evaluate the safety and tolerability of Cenobamate in subjects with POS. To evaluate the effect of Cenobamate in the treatment of POS and specified epilepsy types. To determine the plasma concentration of Cenobamate in subjects with POS.

Start Date29 Jun 2021

Sponsor / Collaborator

Bellwyck Pharma Services Inc

[+3]

CTR20202315 / CompletedPhase 1

一项评估单剂量口服cenobamate在中国健康受试者体内的药代动力学和安全性的I期单中心、随机、双盲、安慰剂对照研究

[Translation] A phase I single-center, randomized, double-blind, placebo-controlled study to evaluate the pharmacokinetics and safety of a single oral dose of cenobamate in healthy Chinese subjects

本研究的主要目的是描述健康中国受试者单剂口服 Cenobamate 后的 Cenobamate 药代动力学（PK）特征。本研究的次要目的是评估健康中国受试者单剂口服 Cenobamate 的安全性。

[Translation]

The primary objective of this study was to characterize the pharmacokinetic (PK) profile of cenobamate after a single oral dose of cenobamate in healthy Chinese subjects. The secondary objective of this study was to evaluate the safety of a single oral dose of cenobamate in healthy Chinese subjects.

Start Date08 Mar 2021

Sponsor / Collaborator

Bellwyck Pharma Services Inc

[+3]

100 Clinical Results associated with Bellwyck Pharma Services Inc

Login to view more data

0 Patents (Medical) associated with Bellwyck Pharma Services Inc

Login to view more data

100 Deals associated with Bellwyck Pharma Services Inc

Login to view more data

100 Translational Medicine associated with Bellwyck Pharma Services Inc

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data